Top 723 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

dashboard United States Biotechnology Industry Analysis
Top US Companies United States Analysis
language World Top Companies language World Companies Analysis
🐷

"Bulls make money...
Bears make money...
Pigs get slaughtered!"

Stop guessing, unlock Financial AI.

(Don't be a pig.)

  • filter_listAdvanced Analysis & Companies Filter

    Country / Territory

    AND / OR

    Sector / Industry

    Stock Index

Top Biotechnology Companies from the United States as of Jan. 01, 2024

Ranking Company Market Cap (USD) Stock Country Sector Industry
1 Vertex Pharmaceuticals Incorporated $107.23 B VRTX wb_incandescent United States Healthcare Biotechnology
2 Regeneron Pharmaceuticals, Inc. $100.01 B REGN wb_incandescent United States Healthcare Biotechnology
3 Seagen Inc. $43.15 B

(Dec. 1, 2023)

SGEN wb_incandescent United States Healthcare Biotechnology
4 Moderna, Inc. $41.43 B MRNA wb_incandescent United States Healthcare Biotechnology
5 Alnylam Pharmaceuticals, Inc. $24.13 B ALNY wb_incandescent United States Healthcare Biotechnology
6 Viela Bio, Inc. $22.50 B VIE wb_incandescent United States Healthcare Biotechnology
7 BioMarin Pharmaceutical Inc. $18.41 B BMRN wb_incandescent United States Healthcare Biotechnology
8 Royalty Pharma plc $16.64 B RPRX wb_incandescent United States Healthcare Biotechnology
9 Incyte Corporation $14.92 B INCY wb_incandescent United States Healthcare Biotechnology
10 Neurocrine Biosciences, Inc. $13.12 B NBIX wb_incandescent United States Healthcare Biotechnology
11 Karuna Therapeutics, Inc. $11.94 B KRTX wb_incandescent United States Healthcare Biotechnology
12 Bio-Techne Corporation $11.45 B TECH wb_incandescent United States Healthcare Biotechnology
13 United Therapeutics Corporation $10.81 B UTHR wb_incandescent United States Healthcare Biotechnology
14 Acceleron Pharma Inc. $10.56 B

(Nov. 1, 2021)

XLRN wb_incandescent United States Healthcare Biotechnology
15 Legend Biotech Corporation $10.56 B LEGN wb_incandescent United States Healthcare Biotechnology
16 Cytokinetics, Incorporated $9.19 B CYTK wb_incandescent United States Healthcare Biotechnology
17 Sarepta Therapeutics, Inc. $8.82 B SRPT wb_incandescent United States Healthcare Biotechnology
18 OncBioMune Pharmaceuticals, Inc. $8.67 B

(Feb. 1, 2022)

OBMP wb_incandescent United States Healthcare Biotechnology
19 ImmunoGen, Inc. $8.25 B IMGN wb_incandescent United States Healthcare Biotechnology
20 Cerevel Therapeutics Holdings, Inc. $7.63 B CERE wb_incandescent United States Healthcare Biotechnology
21 Ionis Pharmaceuticals, Inc. $7.51 B IONS wb_incandescent United States Healthcare Biotechnology
22 Exelixis, Inc. $7.38 B EXEL wb_incandescent United States Healthcare Biotechnology
23 Apellis Pharmaceuticals, Inc. $7.20 B APLS wb_incandescent United States Healthcare Biotechnology
24 Intra-Cellular Therapies, Inc. $6.69 B ITCI wb_incandescent United States Healthcare Biotechnology
25 BridgeBio Pharma, Inc. $6.56 B BBIO wb_incandescent United States Healthcare Biotechnology
26 Immunovant, Inc. $6.19 B IMVT wb_incandescent United States Healthcare Biotechnology
27 Arena Pharmaceuticals, Inc. $6.17 B

(March 1, 2022)

ARNA wb_incandescent United States Healthcare Biotechnology
28 Vaxcyte, Inc. $6.12 B PCVX wb_incandescent United States Healthcare Biotechnology
29 Blueprint Medicines Corporation $5.04 B BPMC wb_incandescent United States Healthcare Biotechnology
30 ACADIA Pharmaceuticals Inc. $4.98 B ACAD wb_incandescent United States Healthcare Biotechnology
31 Prometheus Biosciences, Inc. $4.95 B

(Jan. 1, 2023)

RXDX wb_incandescent United States Healthcare Biotechnology
32 Halozyme Therapeutics, Inc. $4.64 B HALO wb_incandescent United States Healthcare Biotechnology
33 Global Blood Therapeutics, Inc. $4.62 B

(Oct. 1, 2022)

GBT wb_incandescent United States Healthcare Biotechnology
34 Revolution Medicines, Inc. $4.59 B RVMD wb_incandescent United States Healthcare Biotechnology
35 Madrigal Pharmaceuticals, Inc. $4.31 B MDGL wb_incandescent United States Healthcare Biotechnology
36 Insmed Incorporated $4.20 B INSM wb_incandescent United States Healthcare Biotechnology
37 Reata Pharmaceuticals, Inc. $4.19 B

(July 1, 2023)

RETA wb_incandescent United States Healthcare Biotechnology
38 Mirati Therapeutics, Inc. $4.15 B MRTX wb_incandescent United States Healthcare Biotechnology
39 Amicus Therapeutics, Inc. $3.96 B FOLD wb_incandescent United States Healthcare Biotechnology
40 Ultragenyx Pharmaceutical Inc. $3.94 B RARE wb_incandescent United States Healthcare Biotechnology
41 Axsome Therapeutics, Inc. $3.89 B AXSM wb_incandescent United States Healthcare Biotechnology
42 Arrowhead Pharmaceuticals, Inc. $3.82 B ARWR wb_incandescent United States Healthcare Biotechnology
43 Turning Point Therapeutics, Inc. $3.81 B

(Aug. 1, 2022)

TPTX wb_incandescent United States Healthcare Biotechnology
44 ChemoCentryx, Inc. $3.74 B

(Oct. 1, 2022)

CCXI wb_incandescent United States Healthcare Biotechnology
45 Krystal Biotech, Inc. $3.41 B KRYS wb_incandescent United States Healthcare Biotechnology
46 VitaSpring Biomedical Co. Ltd $3.10 B VSBC wb_incandescent United States Healthcare Biotechnology
47 ImmunityBio, Inc. $2.96 B IBRX wb_incandescent United States Healthcare Biotechnology
48 Dicerna Pharmaceuticals, Inc. $2.93 B

(Dec. 1, 2021)

DRNA wb_incandescent United States Healthcare Biotechnology
49 Translate Bio, Inc. $2.82 B

(May 1, 2023)

TBIO wb_incandescent United States Healthcare Biotechnology
50 SpringWorks Therapeutics, Inc. $2.74 B SWTX wb_incandescent United States Healthcare Biotechnology

Top Biotechnology Companies from the United States as of Jan. 01, 2024

3. Seagen Inc.

Market Cap (USD): $43.15 B

(Dec. 1, 2023)

Stock: SGEN wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Seagen Inc. Company Profile

14. Acceleron Pharma Inc.

Market Cap (USD): $10.56 B

(Nov. 1, 2021)

Stock: XLRN wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Acceleron Pharma Inc. Company Profile

18. OncBioMune Pharmaceuticals, Inc.

Market Cap (USD): $8.67 B

(Feb. 1, 2022)

Stock: OBMP wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business OncBioMune Pharmaceuticals, Inc. Company Profile

27. Arena Pharmaceuticals, Inc.

Market Cap (USD): $6.17 B

(March 1, 2022)

Stock: ARNA wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Arena Pharmaceuticals, Inc. Company Profile

31. Prometheus Biosciences, Inc.

Market Cap (USD): $4.95 B

(Jan. 1, 2023)

Stock: RXDX wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Prometheus Biosciences, Inc. Company Profile

33. Global Blood Therapeutics, Inc.

Market Cap (USD): $4.62 B

(Oct. 1, 2022)

Stock: GBT wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Global Blood Therapeutics, Inc. Company Profile

37. Reata Pharmaceuticals, Inc.

Market Cap (USD): $4.19 B

(July 1, 2023)

Stock: RETA wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Reata Pharmaceuticals, Inc. Company Profile

43. Turning Point Therapeutics, Inc.

Market Cap (USD): $3.81 B

(Aug. 1, 2022)

Stock: TPTX wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Turning Point Therapeutics, Inc. Company Profile

44. ChemoCentryx, Inc.

Market Cap (USD): $3.74 B

(Oct. 1, 2022)

Stock: CCXI wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business ChemoCentryx, Inc. Company Profile

48. Dicerna Pharmaceuticals, Inc.

Market Cap (USD): $2.93 B

(Dec. 1, 2021)

Stock: DRNA wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Dicerna Pharmaceuticals, Inc. Company Profile

49. Translate Bio, Inc.

Market Cap (USD): $2.82 B

(May 1, 2023)

Stock: TBIO wb_incandescent

Country: United States

Sector: Healthcare

Industry: Biotechnology

business Translate Bio, Inc. Company Profile